184 related articles for article (PubMed ID: 38474356)
1. Inhibitors of Rho/MRTF/SRF Transcription Pathway Regulate Mitochondrial Function.
Patyal P; Zhang X; Verma A; Azhar G; Wei JY
Cells; 2024 Feb; 13(5):. PubMed ID: 38474356
[TBL] [Abstract][Full Text] [Related]
2. Novel Rho/MRTF/SRF inhibitors block matrix-stiffness and TGF-β-induced fibrogenesis in human colonic myofibroblasts.
Johnson LA; Rodansky ES; Haak AJ; Larsen SD; Neubig RR; Higgins PD
Inflamm Bowel Dis; 2014 Jan; 20(1):154-65. PubMed ID: 24280883
[TBL] [Abstract][Full Text] [Related]
3. Local delivery of novel MRTF/SRF inhibitors prevents scar tissue formation in a preclinical model of fibrosis.
Yu-Wai-Man C; Spencer-Dene B; Lee RMH; Hutchings K; Lisabeth EM; Treisman R; Bailly M; Larsen SD; Neubig RR; Khaw PT
Sci Rep; 2017 Mar; 7(1):518. PubMed ID: 28364121
[TBL] [Abstract][Full Text] [Related]
4. Myocardin-related transcription factors and SRF are required for cytoskeletal dynamics and experimental metastasis.
Medjkane S; Perez-Sanchez C; Gaggioli C; Sahai E; Treisman R
Nat Cell Biol; 2009 Mar; 11(3):257-68. PubMed ID: 19198601
[TBL] [Abstract][Full Text] [Related]
5. Rho/SRF Inhibitor Modulates Mitochondrial Functions.
Patyal P; Nguyen B; Zhang X; Azhar G; Ameer FS; Verma A; Crane J; Kc G; Che Y; Wei JY
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232837
[TBL] [Abstract][Full Text] [Related]
6. Rho-actin signaling to the MRTF coactivators dominates the immediate transcriptional response to serum in fibroblasts.
Esnault C; Stewart A; Gualdrini F; East P; Horswell S; Matthews N; Treisman R
Genes Dev; 2014 May; 28(9):943-58. PubMed ID: 24732378
[TBL] [Abstract][Full Text] [Related]
7. LMO7 mediates cell-specific activation of the Rho-myocardin-related transcription factor-serum response factor pathway and plays an important role in breast cancer cell migration.
Hu Q; Guo C; Li Y; Aronow BJ; Zhang J
Mol Cell Biol; 2011 Aug; 31(16):3223-40. PubMed ID: 21670154
[TBL] [Abstract][Full Text] [Related]
8. Redox modification of nuclear actin by MICAL-2 regulates SRF signaling.
Lundquist MR; Storaska AJ; Liu TC; Larsen SD; Evans T; Neubig RR; Jaffrey SR
Cell; 2014 Jan; 156(3):563-76. PubMed ID: 24440334
[TBL] [Abstract][Full Text] [Related]
9. NG2/CSPG4, CD146/MCAM and VAP1/AOC3 are regulated by myocardin-related transcription factors in smooth muscle cells.
Rippe C; Morén B; Liu L; Stenkula KG; Mustaniemi J; Wennström M; Swärd K
Sci Rep; 2021 Mar; 11(1):5955. PubMed ID: 33727640
[TBL] [Abstract][Full Text] [Related]
10. Muscle-specific signaling mechanism that links actin dynamics to serum response factor.
Kuwahara K; Barrientos T; Pipes GC; Li S; Olson EN
Mol Cell Biol; 2005 Apr; 25(8):3173-81. PubMed ID: 15798203
[TBL] [Abstract][Full Text] [Related]
11. Myocardin and myocardin-related transcription factor-A synergistically mediate actin cytoskeletal-dependent inhibition of liver fibrogenesis.
Shi Z; Ren M; Rockey DC
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G504-G517. PubMed ID: 31928221
[TBL] [Abstract][Full Text] [Related]
12. Sphingosine 1-phosphate stimulates smooth muscle cell differentiation and proliferation by activating separate serum response factor co-factors.
Lockman K; Hinson JS; Medlin MD; Morris D; Taylor JM; Mack CP
J Biol Chem; 2004 Oct; 279(41):42422-30. PubMed ID: 15292266
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of myocardin-related transcription factor/serum response factor signaling decreases lung fibrosis and promotes mesenchymal cell apoptosis.
Sisson TH; Ajayi IO; Subbotina N; Dodi AE; Rodansky ES; Chibucos LN; Kim KK; Keshamouni VG; White ES; Zhou Y; Higgins PD; Larsen SD; Neubig RR; Horowitz JC
Am J Pathol; 2015 Apr; 185(4):969-86. PubMed ID: 25681733
[TBL] [Abstract][Full Text] [Related]
14. Myocardin-related transcription factor-A complexes activate type I collagen expression in lung fibroblasts.
Luchsinger LL; Patenaude CA; Smith BD; Layne MD
J Biol Chem; 2011 Dec; 286(51):44116-44125. PubMed ID: 22049076
[TBL] [Abstract][Full Text] [Related]
15. SRF Co-factors Control the Balance between Cell Proliferation and Contractility.
Gualdrini F; Esnault C; Horswell S; Stewart A; Matthews N; Treisman R
Mol Cell; 2016 Dec; 64(6):1048-1061. PubMed ID: 27867007
[TBL] [Abstract][Full Text] [Related]
16. Cyclase-associated protein 2 (CAP2) controls MRTF-A localization and SRF activity in mouse embryonic fibroblasts.
Kepser LJ; Khudayberdiev S; Hinojosa LS; Macchi C; Ruscica M; Marcello E; Culmsee C; Grosse R; Rust MB
Sci Rep; 2021 Feb; 11(1):4789. PubMed ID: 33637797
[TBL] [Abstract][Full Text] [Related]
17. CCG-1423: a small-molecule inhibitor of RhoA transcriptional signaling.
Evelyn CR; Wade SM; Wang Q; Wu M; Iñiguez-Lluhí JA; Merajver SD; Neubig RR
Mol Cancer Ther; 2007 Aug; 6(8):2249-60. PubMed ID: 17699722
[TBL] [Abstract][Full Text] [Related]
18. Umbilical cord/placenta-derived mesenchymal stem cells inhibit fibrogenic activation in human intestinal myofibroblasts via inhibition of myocardin-related transcription factor A.
Choi YJ; Koo JB; Kim HY; Seo JW; Lee EJ; Kim WR; Cho JY; Hahm KB; Hong SP; Kim DH; Yoo JH
Stem Cell Res Ther; 2019 Sep; 10(1):291. PubMed ID: 31547873
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the Muscarinic M
Liu L; Rippe C; Hansson O; Kryvokhyzha D; Fisher S; Ekman M; Swärd K
Front Physiol; 2021; 12():710968. PubMed ID: 34539433
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of TRPM7 blocks MRTF/SRF-dependent transcriptional and tumorigenic activity.
Voringer S; Schreyer L; Nadolni W; Meier MA; Woerther K; Mittermeier C; Ferioli S; Singer S; Holzer K; Zierler S; Chubanov V; Liebl B; Gudermann T; Muehlich S
Oncogene; 2020 Mar; 39(11):2328-2344. PubMed ID: 31844251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
